Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Acute Kidney Injury (AKI): later-stage trial registry
3 of 5 indexed Acute Kidney Injury (AKI) trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Acute Kidney Injury (AKI): 5 US clinical trials tracked, 3 recruiting.
Acute Kidney Injury (AKI) is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Vantive Health, running 2 of these trials.
Enrollment posture brief
Registry condition acute-kidney-injury-aki
OPEN 3 | RECR 60% | LATE 2 | EARLY 1 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Stress Disorder (60% recruiting · 5 trials)
Acute Kidney Injury (AKI) lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Acute Kidney Injury (AKI) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Acute Kidney Injury (AKI) is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Acute Kidney Injury (AKI) research.
Vantive Health accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Acute Kidney Injury (AKI) enrolment sits around 100 participants.
Median target enrolment is 100 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Acute Kidney Injury (AKI) research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
University of California, San Francisco
NCT06802224
NIRS Monitoring in the NICU and AKI
NYU Langone Health
NCT07222722
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
Vantive Health
NCT05399537
Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery
Astellas Pharma
NCT03941483
Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry
Vantive Health
NCT06633029
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Acute Kidney Injury (AKI) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Acute Kidney Injury (AKI) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Acute Kidney Injury (AKI) page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Acute Kidney Injury (AKI) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Vantive Health sponsors the most Acute Kidney Injury (AKI) trials on record, review their full trial history before evaluating a specific study. See Vantive Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Kidney Injury (AKI) condition card totals 5 registered trials; most-linked intervention Prismaflex HF20; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.